Philippe Montcuquet

Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases

C Jacquillat, D. Khayat, Pierre Banzet et al. · Cancer · 1990 · 241 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +12

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

P. Fumoleau, Henri Roché, Pierre Kerbrat et al. · Annals of Oncology · 2005 · 108 citations · Full text

Medicine, Cardiology, Oncology +17

Long-Term Cardiac Follow-Up in Relapse-Free Patients After Six Courses of Fluorouracil, Epirubicin, and Cyclophosphamide, With Either 50 or 100 mg of Epirubicin, As Adjuvant Therapy for Node-Positive Breast Cancer: French Adjuvant Study Group

Jacques Bonneterre, Henri Roché, Pierre Kerbrat et al. · Journal of Clinical Oncology · 2004 · 99 citations · Full text

Medicine, Cardiology, Oncology +16

Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis

Elsa Curtit, Virginie Nerich, Laura Mansi et al. · The Oncologist · 2013 · 96 citations · Full text

Medicine, Endocrinology, Oncology +17